Angels for Change offers comment on Dept. of Commerce 232 Section Investigation

Angels for Change submitted formal comments to the U.S. Department of Commerce Section 232 investigation into pharmaceutical imports and national security. Our statement respectfully urges the Administration to exempt essential pharmaceutical products—especially Generic Sterile Injectables (GSIs)—from potential tariffs, which could worsen the already fragile drug supply chain and lead to increased shortages.

We highlighted the economic and systemic drivers behind drug shortages and shared our concerned that, given these broken economics, pharmaceutical tariffs would inadvertently cause disruptions that could have devastating impacts on routine and critical health care in the United States for patients.

Our recommendations include payment reform to reward manufacturing reliability and resiliency, partnering with multi-stakeholder groups to build the resiliency, and investment in mitigation tools like our Drug Shortage Hotline, Project PROTECT and Project GOLD.

View the full submission.

Fox 8 Investigates Shortages of Prescription Drugs

Shortages of Prescription Drugs: Investigating the Causes of Shortfalls and Possible Solutions

Thank you Fox 8 for shedding light on the thousands of patients that are forced to ration or go without prescriptions they need due to limited supply. Fox 8 investigators go in-depth as to why this happens.

Increasing awareness of the issue brings us one step closer to solving the drug shortage crisis.

Local woman credits nonprofit amid I.V. fluid shortage

Angels for Change was recently featured in a powerful News10 story highlighting our mission to end drug shortages and the critical impact our work has on patients across the country. The piece shares the story of Brooke, a patient in Warrensburg, N.Y., who faced a terrifying delay in receiving her IV fluid treatments due to a national shortage.

When traditional supply chain solutions failed, Brooke and her mother, Cathy, turned to Angels for Change. Through our national network and rapid advocacy efforts, we were able to help locate the essential IV fluids she needed to continue her care, demonstrating once again how patient-centered advocacy can make a life-saving difference.

Behind every shortage is a real person with real needs. Thank you, News10, for raising awareness around the drug shortage crisis. We are committed to advocating for patients, raising awareness, and building a more resilient and equitable pharmaceutical supply chain.

Watch the news segment below and read the news article here.

India To Improve Pharma Standards

Bad Medicine: Why India Is Racing To Improve Pharma Standards Amid US-China Trade Rivalry | Insight

As drug shortages continue to threaten lives, a new geopolitical shift could shape where our medicines come from—and how safe they are. Thank you CNA Insider for investigating this crucial topic. A resilient drug supply chain is not just about availability, it’s about quality, transparency, and accountability.